CD8A and neoplasm: Notably, dual ablation of PRDM1 and NR4A3 successfully counteracted T cell exhaustion and exhibited superior antitumor capacity, with increased frequency of stem cell–like TIM-3–TCF1+CD8+ T cells in both tumor and peripheral blood (7).